Effectiveness of trans-cervical foley catheter and intra-vaginal Misoprotol for pre induction cervical ripening
Conditions
Interventions
A patient who will be decided to undergo labour and who meet the criteria for the study will be randomized to receive either trans-cervical foley catheters or intra-vaginal misoprostol as the pre- ind
Sponsors
None
Eligibility
Inclusion criteria
Inclusion criteria: Consented women with singleton gestation in vertex presentation at greater than 28 weeks gestation with Bishop’s score less than 6
Exclusion criteria
Exclusion criteria: •Rupture of membranes antepartum bleeding •active genital herpes infection •fetal death •placenta praevia •previous induction or pre-induction agent during the pregnancy, and known allergy to misoprostol •Women with history of cesarean deliveries will not be excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to vaginal delivery or vaginal delivery rates within a specified time Operative delivery rates (caesarean section and instrumental vaginal delivery) •Length of labour/incidence of prolonged labour •Measures of effectiveness (oxytocin augmentation rates •epidural usage •cervix unfavorable/unchanged at 12–24 hours) •Serious maternal morbidity or death •Other adverse outcomes (e.g. uterine hypercontractility •Postpartum haemorrhage •Maternal adverse effects) •Measures of maternal satisfaction •Serious neonatal morbidity or perinatal death •Other adverse perinatal outcomes (meconium-stained liquor •Five-minute apgar score of less than seven •Neonatal intensive care unit admission) [] | — |
Secondary
| Measure | Time frame |
|---|---|
| None [] | — |
Countries
Sri Lanka
Contacts
Public ContactDr. T.D. Dias
Senior Registrar
Outcome results
None listed